Robert Plenge, EVP & Chief Research Officer, BMS: Reinventing Drug Discovery
Synopsis: The drug discovery industry faces a persistent challenge: 9 out of 10 drugs entering the clinic fail, underscoring the need for a better path from biological insight to transformative medi...
24 Sep 45min
Nello Mainolfi, Founder, President & CEO, Kymera: Pioneering Targeted Protein Degradation
Synopsis: What does it take to turn a once-fringe scientific idea into a new approach to drug discovery—and build a biotech company around it for the long haul? In this episode of Biotech 2050, hos...
16 Sep 38min
Nick Myerberg, Partner & Head of AI at Braidwell on AI's Next Era in Drug Discovery
Synopsis: The guest on today's podcast is a representative of Braidwell LP, a registered investment adviser. Braidwell invests on behalf of its clients and either holds, or may in the future hold, p...
3 Aug 47min
Robert Jacks, CEO of Sparrow Pharmaceuticals | Precision Medicine, Biotech Strategy & Leadership
Synopsis: In an industry often defined by rapid innovation and high-stakes science, long-term success in biotech requires more than breakthrough discoveries—it demands strategic clarity, resilient l...
22 Jul 34min
Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients
Synopsis: While biotech is increasingly measured by clinical milestones and financial outcomes, Rahul Chaturvedi welcomes two leaders who argue that true success begins and ends with patients. In th...
10 Jun 41min
Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision
Synopsis: At the intersection of personal mission and biotech leadership, Rahul Chaturvedi sits down with Catherine Owen Adams, CEO of Acadia Pharmaceuticals, for a deeply personal and strategically...
13 Mai 33min
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
Synopsis: This episode is proudly sponsored by Quartzy. At a time when biotech innovation is being reshaped by science, capital, and global dynamics, Alok Tayi sits down with Barry Quart, CEO of Co...
16 Apr 23min
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
Synopsis: Addiction is often misunderstood as a failure of willpower—but emerging science increasingly shows it may be deeply rooted in biology. In this episode of Biotech 2050, recorded during JPM...
6 Mar 14min
